A combination of peritumoral radiomics features appeared to improve the predictive performance of intratumoral radiomics to estimate pathological complete response after neoadjuvant chemoradiation in patients with esophageal squamous cell carcinoma.
Predicting Tumor Response Using Combo of Peritumoral Radiomics Features Appears Effective